Visitor Monitoring Drug History: CAPITAL SOLEIL 15
 
Drugs Directory of False Positives DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST
 
Browse by Letter: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Label and Approval History

Drug Name: CAPITAL SOLEIL 15
FDA Application No: (NDA) 021501
Active Ingredient(s): AVOBENZONE; ECAMSULE; OCTOCRYLENE
Company: LOREAL USA
 
Label History
 
View the label approved on June 7, 2007 for CAPITAL SOLEIL 15, (NDA) 021501


To see older, previously-approved labels, go to the "Approval History" section of this page. Older labels are for historical information only and should not be used for clinical purposes.
 
 
 
Approval History
 
Action DateSupplement NumberSort imageApproval TypeLetters, Reviews, Labels, Patient Package Insert
6/8/2007 003Labeling Revision Letter
Label 
4/24/2007 001Labeling Revision Letter
Label 
10/2/2006 000Approval Letter 
 
©2019 Drugs That Causes a False Positive on a Drug Test